NEURAXIS, INC. Amortization of Debt Issuance Costs
NEURAXIS, INC. (NRXS) reported Amortization of Debt Issuance Costs of $21.86 thousand for the 12-month period ending 2024-12-31, per its 10-Q filed 2024-05-20.
Discontinued › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-05-20
| Period end | Amortization of Debt Issuance Costs 12 month |
|---|---|
| 2024-12-31 | $21.86K 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |